$2.76
-0.60-17.86%
At close: -
$2.80
0.041.45%
After Hours: May 2, 7:58 PM EDT
Comments
Loading...
Phathom Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:PHAT | Benzinga
Phathom Pharmaceuticals Inc has a consensus price target of $19.5 based on the ratings of 9 analysts. The high is $30 issued by BMO Capital on March 1, 2023. The low is $5 issued by Goldman Sachs on May 2, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Guggenheim, and HC Wainwright & Co. on May 2, 2025, respectively. With an average price target of $12.33 between Goldman Sachs, Guggenheim, and HC Wainwright & Co., there's an implied 340.48% upside for Phathom Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Guggenheim
HC Wainwright & Co.
Needham
Stifel
1calculated from analyst ratings
Analyst Ratings for Phathom Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/02/2025 | Buy Now | 78.57% | Goldman Sachs | Paul Choi60% | $10 → $5 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | 328.57% | Guggenheim | Yatin Suneja50% | $18 → $12 | Maintains | Buy | Get Alert |
| 05/02/2025 | Buy Now | 614.29% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $20 | Maintains | Buy | Get Alert |
| 04/21/2025 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2025 | Buy Now | 257.14% | Goldman Sachs | Paul Choi60% | $12 → $10 | Maintains | Neutral | Get Alert |
| 04/09/2025 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2025 | Buy Now | — | Guggenheim | Yatin Suneja50% | — | Reiterates | Buy → Buy | Get Alert |
| 04/02/2025 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | Buy Now | 328.57% | Goldman Sachs | Paul Choi60% | $18 → $12 | Maintains | Neutral | Get Alert |
| 03/07/2025 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2025 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | Buy Now | 900% | Needham | Joseph Stringer53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 08/30/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 08/23/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 08/19/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | 328.57% | Goldman Sachs | Paul Choi60% | $10 → $12 | Maintains | Neutral | Get Alert |
| 07/26/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 07/22/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2024 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 07/08/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/14/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | 757.14% | Stifel | Annabel Samimy67% | → $24 | Initiates | → Buy | Get Alert |
| 04/26/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 04/05/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 02/23/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $26 → $26 | Reiterates | Buy → Buy | Get Alert |
| 01/05/2024 | Buy Now | 828.57% | Needham | Joseph Stringer53% | $23 → $26 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 11/03/2023 | Buy Now | 257.14% | Goldman Sachs | Paul Choi60% | $9 → $10 | Maintains | Neutral | Get Alert |
| 09/27/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | Buy Now | 900% | HC Wainwright & Co. | Matthew Caufield38% | → $28 | Initiates | → Buy | Get Alert |
| 06/12/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | → Buy | Get Alert |
| 05/11/2023 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Upgrade | In-Line → Outperform | Get Alert |
| 04/19/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | → Buy | Get Alert |
| 04/05/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | → $23 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | Buy Now | 650% | Craig-Hallum | Chase Knickerbocker52% | → $21 | Initiates | → Buy | Get Alert |
| 03/01/2023 | Buy Now | 971.43% | BMO Capital | Gary Nachman58% | $35 → $30 | Maintains | Outperform | Get Alert |
| 02/10/2023 | Buy Now | 721.43% | Needham | Joseph Stringer53% | $25 → $23 | Maintains | Buy | Get Alert |
| 01/04/2023 | Buy Now | 1150% | BMO Capital | Gary Nachman58% | $38 → $35 | Maintains | Outperform | Get Alert |
| 01/04/2023 | Buy Now | 792.86% | Needham | Joseph Stringer53% | $38 → $25 | Maintains | Buy | Get Alert |
| 11/14/2022 | Buy Now | 1257.14% | BMO Capital | Gary Nachman58% | $45 → $38 | Maintains | Outperform | Get Alert |
| 11/11/2022 | Buy Now | 971.43% | Guggenheim | Yatin Suneja50% | $42 → $30 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 471.43% | Jefferies | Glen Santangelo50% | → $16 | Initiates | → Buy | Get Alert |
| 08/03/2022 | Buy Now | 221.43% | Goldman Sachs | Paul Choi60% | $15 → $9 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | 1257.14% | Needham | Joseph Stringer53% | $44 → $38 | Maintains | Buy | Get Alert |
| 05/24/2022 | Buy Now | 435.71% | Goldman Sachs | Paul Choi60% | $32 → $15 | Maintains | Neutral | Get Alert |
| 05/06/2022 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Downgrade | Outperform → In-Line | Get Alert |
FAQ
What is the target price for Phathom Pharmaceuticals (PHAT) stock?
The latest price target for Phathom Pharmaceuticals (NASDAQ:PHAT) was reported by Goldman Sachs on May 2, 2025. The analyst firm set a price target for $5.00 expecting PHAT to rise to within 12 months (a possible 78.57% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phathom Pharmaceuticals (PHAT)?
The latest analyst rating for Phathom Pharmaceuticals (NASDAQ:PHAT) was provided by Goldman Sachs, and Phathom Pharmaceuticals maintained their neutral rating.
When was the last upgrade for Phathom Pharmaceuticals (PHAT)?
The last upgrade for Phathom Pharmaceuticals Inc happened on May 11, 2023 when Evercore ISI Group raised their price target to N/A. Evercore ISI Group previously had an in-line for Phathom Pharmaceuticals Inc.
When was the last downgrade for Phathom Pharmaceuticals (PHAT)?
The last downgrade for Phathom Pharmaceuticals Inc happened on May 6, 2022 when Evercore ISI Group changed their price target from N/A to N/A for Phathom Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Phathom Pharmaceuticals (PHAT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phathom Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phathom Pharmaceuticals was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.
Is the Analyst Rating Phathom Pharmaceuticals (PHAT) correct?
While ratings are subjective and will change, the latest Phathom Pharmaceuticals (PHAT) rating was a maintained with a price target of $10.00 to $5.00. The current price Phathom Pharmaceuticals (PHAT) is trading at is $2.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
